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Figure 8. Kirby-Bauer tests against (A) S.cerevisiae, (B) and B. cereus
A
B
Figure 1. (Left) transformation of homocysteine to methionine byMetSyn
(Right) binding of methylated folate and methionine in MetSyn
Figure 9.MetSyn inhibition assay, showing comparitive levels of
inhibition by synthesized molecules
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Preliminary Inhibitor Screening
Figure 4. Synthesis of deazaguanine and with linker
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Figure 5. Synthesis of protected amino acid tail
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Figure 6. Coupling of amino acid tail to linker
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Fungal infections are a common public health
concern in regards to immuno-compromised
patients who have a much higher mortality rate due
to their condition.1 Methionine Synthase (MetSyn),
is an enzyme which converts homocysteine to
methionine using a methylated folate molecule
(Figure 1). Due to the close binding of homocysteine
and folate in the fungal enzyme2,3, molecules can be
As MetSyn converts homocysteine to methionine,
MetSyn activity can be detected by homocysteine
concentration. The MeasureIT-thiol quantification
assay gives a fluorescent response in proportion to
Hcy concentration. High fluorescence shows large
concentration of Hcy, allowing the method to be
adapted to show enzyme activity. High fluorescence
compared to control shows inhibition of the enzyme
when mixed with our novel inhibitors, while low
fluorescence shows consumed Hcy, showing poor
inhibition.
Figure 7. Current library of inhibitors, and inhibitor design
synthesized to selectively
inhibit the fungal enzyme,
providing a safer anti-
fungal treatment (Figure 2).
Folate Mimic Linker Amino Acid Tail Potential MetSyn Inhibitors
Fungal infections are of continuous concern,
especially with regard to immunocompromised
patients. In an effort to develop new potential anti-
fungal agents, we have begun synthesizing a library
of potential inhibitors of the fungal Methionine
Synthase (MetSyn) enzyme. Key differences between
the B₁₂-independant fungal MetSyn enzyme and the
B₁₂-dependant mammalian form can allow for an
antifungal drug to be developed to exclusively bind
the fungal enzyme and inhibit fungal growth while
leaving the host (patient) unaffected. We are
currently exploring the synthesis of various pterin
and deazaguanine-based molecules as these mimic
folate, an essential substrate forMetSyn function.We
have begun testing these new molecules for activity
in a fungal growth assay, as well as a fluorescent assay
for monitoring MetSyn activity.
Multiple routes of synthesis to the folate mimic 7-
carboxymethyl pterin (7-CMP) were conceived of
and tested. Path A produced slightly better yields,
where Path B allowed for quick synthesis and easy
purification. This led to Path B to be our method of
choice for 7-CMP synthesis (Figure 3).
The linker is then coupled to the amino acid tail, and
deprotected, affording a potential inhibitor (Figure
6). A library of molecules has been prepared
(Figure 7) and tested on various fungi and bacteria
via Kirby-Bauer test, showing inhibitors H, N, and
A with large zones of inhibition in comparison to
the positive control (Figure 8).
In conclusion, our inhibitors show promise in
regards to inhibiting the enzyme methionine
synthase. More work is being done in testing the
enzymes directly on fungi and bacteria, as well as
cancer cell lines. Folate pathway inhibitors have also
been shown to be potent anti-cancer drugs, such as
methotrexate, so ours may show activity as well.
In a representative synthesis of an inhibitor, a
deazaguanine mimic is made, allowing the coupling
of a furan linker’s amine to the deazaguanine,
creating an amide (Figure 4). Synthesis of the
protected amino acid tail begins with a protected
asparagine, followed by the Hoffman rearrangement,
and the addition of CBZ and t-butyl ester (Figure 5).
Background
Figure 2. Cartoon of molecule binding to both binding sites of the
fungal MetSyn vs. failing to bind in the human enzyme
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Figure 3. Various synthetic routes to 7-carboxymethyl pterin
